Chaitanya Divgi
Nuclear Medicine · New York, NYNPI 1376520502
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $2,159,999 of the $2,216,147 with a category attached, or 97.5%. 9 manufacturers reported payments, led by Janssen Research & Development, LLC at 51.5% of the total. Reporting peaked in 2023 at $917,716 and has fallen 99.5% since, to $5,000 in 2025. Among nuclear medicine clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 146 payments — averaging $15,179 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Janssen Research & Development, LLC$1.1M
- Reflexion Medical, Inc.$1M
- Ipsen Pharma SAS$20K
- Y-mabs Therapeutics, Inc.$5K
- Merck$2K
- Siemens Medical Solutions USA, Inc.$138
- plus $117 from 3 others
What the payments were for
- Consulting fees$2,159,99997%
- Speaking & faculty fees$1110%
- Travel & lodging$55,2482%
- Food & beverage$6110%
- Gifts$1780%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Janssen Research & Development, LLC | 102 | $1,142,288 |
| Reflexion Medical, Inc. | 36 | $1,045,829 |
| Ipsen Pharma SAS | 1 | $20,335 |
| Y-mabs Therapeutics, Inc. | 2 | $5,000 |
| Merck | 1 | $2,440 |
| Siemens Medical Solutions USA, Inc. | 1 | $138 |
| Astellas Pharma US Inc | 1 | $70 |
| Janssen Global Services, LLC | 1 | $34 |
| Curium US LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,216,147 in reported general payments places this provider in the 95th percentile of 84 nuclear medicine providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ventolin HfaAlbuterol Sulfate | 16 | $812 |
Paid to pharmacies, not to this prescriber.
Other nuclear medicine in New York
- Steven LarsonNew York$83K
- Ernest DepueyNew York$24K
- Chun KimNew York$22K
- Sean WhalenNew York$22K
- Nasrin GhesaniNew York$10K
- Bilal OmeryNew York$7K
- Mikhail DoubrovinNew York$3K
- Sampanna RayamajhiNew York$2K
- Vetri Sudar JayaprakasamNew York$1K
- Heiko SchoderNew York$889
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.